RE:RE:RE:RE:RE:RE:RE:News release!Eoganacht wrote: How does one go about determining a fair rate of return from a life-saving treatment? A lot of money needs to be recouped from researching and developing the treatment and shareholders need to be compensated for their investment, otherwise why would anyone invest? Or develop treatments? On the other hand, gouging the sick to line your pockets is not acceptable. The original figure of $50,000 from Roger White was based on what it was thought patients would be willing to pay. How do you determine a fair price?
CAinPlap wrote: I guess CFO of a biotech is not in my future. I could not in good conscience charge someone a quarter million to stay alive just because that is the going rate or "because I can".
So are we dealing with profit takers or shorters/manipulators causing the drop today?
I think this is a great question. We have seen major price inflation in medicine over the last 50 or so years. I think part of the TLT strategy for starting with NMIBC was to charge a premium against US Medicare and or US insurance companies, which are paying the high prices. So getting this approved through the FDA is key.
In Canada It is whatever deal $$ TLT can strike with their government.
$50K US per treatment, for say 2 total treatments, to essentially 'cure' bladder cancer is quite a discount(bargain) for the US insurance companies to pay compared to current SoC.
For the average person to pay out of pocket they would have to do a money raise through gofundme, until the medical industry gets back to some sort of free market.